QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

COLL

QT68Collegium Pharmaceutical, Inc.
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·USA
Latest market price
33.54
-0.14-0.42%
OverviewShort InterestFilings
COLLQT68Collegium Pharmaceutical, Inc.·NASDAQ
OverviewShort InterestFilings
33.54-0.42%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01LNTH+0.65%$103.86
Snapshot
Index-P/E-EPS (ttm)
2.04
Insider Own21.02%
Shs Outstand32.43M
Perf Week-2.33%
Market Cap1.09BForward P/E4.41EPS next Y7.61Insider Trans-0.09%Shs Float-Perf Month-0.24%
Enterprise Value-PEG-EPS next Q1.68Inst Own-Short Float-Perf Quarter-7.60%
Income-P/S-EPS this Y278.42%Inst Trans-Short Ratio-Perf Half Y-31.14%
Sales-P/B-EPS next Y-1.40%ROA-Short Interest-Perf YTD-27.56%
Book/sh9.62P/C-EPS next 5Y6.60%ROE-52W High50.79 -33.96%Perf Year13.93%
Cash/sh13.01P/FCF-EPS past 3/5Y-ROIC-52W Low29.11 15.22%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y18.95% 20.30%Gross Margin-Volatility3.93% 2.90%Perf 5Y-
Dividend TTM-EV/Sales-EPS Y/Y TTM315.59%Oper. Margin-ATR (14)1.39Perf 10Y-
Dividend Ex-Date-Quick Ratio-Sales Y/Y TTM26.15%Profit Margin-RSI (14)47.75Recom2.42
Dividend Gr. 3/5Y-Current Ratio-EPS Q/Q18.12%SMA200.14%Beta0.41Target Price58.00
Payout-Debt/Eq-Sales Q/Q8.99%SMA50-1.76%Rel Volume1.42Prev Close33.68
Employees357LT Debt/Eq3.01EarningsAug 06SMA200-14.67%Avg Volume446.41KPrice33.54
IPO DateMay 07, 2015Option/ShortYes / YesEPS/Sales Surpr.15.79% 5.43%Net Debt/EBITDA-Volume631,873Change-0.42%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-10-26ReiteratedTruist Financial$55 → $58
Jan-09-26ReiteratedH.C. WainwrightBuy$46 → $60
Jan-09-26ReiteratedBarclaysOverweight$58 → $56
Jan-07-26ReiteratedTruist Financial$47 → $55
Dec-08-25InitiatedBarclaysOverweight$58
Feb-04-25ReiteratedPiper SandlerNeutral$37 → $36
Jan-10-25UpgradeNeedhamHold → Buy
Nov-11-24ReiteratedJefferiesBuy$44 → $40
Sep-04-24ReiteratedH.C. WainwrightBuy$47 → $50
Aug-09-24ReiteratedPiper SandlerNeutral$39 → $37
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue796781631
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A313317254
Gross Profit482463377
Selling, General and Administrative Excl. Other208276183
Research and Development000
Other Operating Expense85024
Operating Income190187170
Interest Expense1638274
Unusual Expense
———
Non-Operating Income (Expense)-8212-3
Net Income Before Taxes1089399
Income Taxes333029
Consolidated Net Income756369
Net Income From Continuing Operations756369
Net Income756369
EPS (Recurring)2.371.982.14
EPS (Basic, Before Extraordinaries)2.371.982.14
EPS (Diluted)2.041.731.86
EBITDA611401342
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio16.4426.76—
Price To Sales Ratio1.351.90—
Gross Margin60.5559.2859.75
Operating Margin23.8723.9426.94
Net Margin9.428.0710.94
Shares Outstanding323232
Market Capitalization1,0731,482—
Operating Lease Expense
———
Insider Trading Volume
$34.68$32.20$29.73$27.25$24.77● Close Price0.00M0.76M1.52M2.27M3.03MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
SANTINI GINODirectorJun 08 '26Option Exercise16.4917,400286,926112,483Jun 10 12:00 AM
Freund John GordonDirectorMay 18 '26Sale34.052068183,952May 20 12:00 AM
Freund John GordonDirectorMay 15 '26Option Exercise16.4917,400286,92688,099May 18 12:00 AM
Freund John GordonDirectorMay 15 '26Sale34.544,127142,54783,972May 18 12:00 AM
Lurker NancyDirectorMay 13 '26Sale35.974,500161,86118,017May 15 12:00 AM
BOHLIN GAREN GDirectorMay 11 '26Option Exercise16.4917,400286,92670,959May 13 12:00 AM
BOHLIN GAREN GDirectorMay 11 '26Sale37.188,700323,49162,259May 13 12:00 AM
Dieter DavidEVP & General CounselMar 18 '26Sale34.9213,976488,09977,071Mar 20 12:00 AM
Dreyer ScottEVP & Chief Commercial OfficerMar 03 '26Sale40.4149,9762,019,43671,770Mar 05 12:00 AM
Dreyer ScottEVP & Chief Commercial OfficerDec 08 '25Option Exercise15.9035,200559,680121,213Dec 10 12:00 AM
Dreyer ScottEVP & Chief Commercial OfficerDec 08 '25Sale48.1717,600847,856103,613Dec 10 12:00 AM
Balice-Gordon Rita J.DirectorDec 05 '25Sale47.033,650171,67352,629Dec 09 12:00 AM
Fallon John A.DirectorNov 12 '25Option Exercise12.4169,706865,15699,487Nov 14 12:00 AM
Fallon John A.DirectorNov 12 '25Sale47.2134,8531,645,53664,634Nov 14 12:00 AM
Tupper ColleenEVP & Chief Financial OfficerNov 06 '25Sale40.5330,0001,215,753126,667Nov 07 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR